- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Dr. Reddy's Laboratories Limited — Updates, 24-11-2025: Press Release
24-11-2025 | 03:48 pm
24-11-2025 | 03:48 pm
Dr. Reddy's secured European marketing approval for AVT03, its biosimilar to Prolia® and Xgeva®. This development enables commercialization of treatments for osteoporosis and cancer-related bone complications across Europe.
No comments yet. Be the first to comment!